文献速递前列腺癌

模板引导经会阴饱和前列腺穿刺活检检出与未检出病灶的比较

Comparison of lesions detected and undetected by template-guided transperineal saturation prostate biopsy.
PubMed 文献 · BJU Int · 2017-08-22

本研究评估根治性前列腺切除标本中病灶特征,比较系统经会阴超声引导11区活检检出与未检出病灶在肿瘤体积、Gleason评分、手术切缘、空间位置及临床显著性上的差异,并评估未检出临床显著病灶的潜在影响。结果显示临床显著病灶检出率为64%(170/264),未检出病灶多为小肿瘤体积,约20-30%患者存在与检出病灶不同叶或不同象限的未检出临床显著病灶。

要点

  • 模板引导经会阴饱和前列腺活检检出约三分之二的临床显著病灶。
  • 未检出病灶与检出病灶在肿瘤体积、Gleason评分及临床显著性上存在显著差异。
  • 约20-30%患者存在与检出病灶不同叶或不同象限的未检出临床显著病灶。

核心结论

  • 模板引导经会阴饱和前列腺穿刺活检检出约三分之二的临床显著病灶。
  • 未检出病灶大多为小肿瘤体积。
  • 约20-30%患者存在与检出病灶不同叶或不同象限的未检出临床显著病灶。

研究设计与样本

  • 评估根治性前列腺切除标本中病灶特征,比较系统经会阴超声引导11区活检检出与未检出病灶的差异。
  • 中位穿刺针数为24。
  • 纳入129例患者。

主要发现

  • 临床显著病灶检出率为64%(170/264)。
  • 检出与未检出病灶在肿瘤体积、Gleason评分和临床显著性方面存在显著差异。
  • 活检与根治标本在前后区和左右侧的病灶位置不一致率分别为3.4%(7/203)和5.4%(11/203)。
  • 129例患者中,13例(10.1%)存在与检出临床显著病灶同侧但不同区的未检出临床显著病灶。
  • 129例患者中,23例(17.8%)存在与检出临床显著病灶对侧的未检出临床显著病灶。

关键数值与推荐

  • 临床显著病灶检出率64%(170/264)。
  • 前后区病灶位置不一致率3.4%(7/203),左右侧不一致率5.4%(11/203)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the characteristics of lesions detected or undetected by template-guided transperineal saturation prostate biopsy and to evaluate the potential impact of undetected lesions. MATERIALS AND METHODS: We evaluated the characteristics of lesions in radical prostatectomy (RP) specimens, compared the differences between lesions detected and undetected by systematic transperineal ultrasonography-guided 11-region biopsy with regard to tumour volume, Gleason score, surgical margin, spatial location and clinical significance, and assessed the potential impact of undetected clinically significant lesions. RESULTS: The median number of biopsy cores was 24. Sixty-four percent of the clinically significant lesions (170/264) were detected. There were significant differences between the detected and undetected lesions in tumour volume, Gleason score and clinical significance. Inconsistencies found in lesion position between biopsy and RP specimens in the anterior and posterior zones and the left and right sides was 3.4% (7/203) and 5.4% (11/203), respectively. Of the 129 patients, 13 (10.1%) were found to have undetected clinically significant lesions in the biopsy lying on the same side but in a different zone from the detected clinically significant lesions, whereas 23 patients (17.8%) had undetected clinically significant lesions in the biopsy lying on the opposite side from the detected clinically significant lesions. CONCLUSIONS: Template-guided transperineal saturation prostate biopsy detected approximately two-thirds of clinically significant lesions. Most of the undetected lesions were those with small tumour volume. Approximately 20-30% of patients had clinically significant undetected lesions in a different lobe or different quadrant from the detected lesions in the biopsy.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Mai Z, Xiao Y, Yan W, et al. Comparison of lesions detected and undetected by template-guided transperineal saturation prostate biopsy. BJU Int. 2017. PMID: 28771912. doi:10.1111/bju.13977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。